Optimizing Implementation of Long Acting Injectable PrEP
Starting soon · Not applicable
Conditions studied: HIV Infections
In brief
Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available
Key facts
- Study ID
- NCT07649551
- Run by
- University of Minnesota
- People needed
- 20
- Starts
- 2027-01-01
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.